v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
ASSETS    
Cash and cash equivalents $ 1,444,562 $ 3,039,343
Grants receivable 302,863 517,359
Prepaid expenses and other current assets 342,545 382,886
Total current assets 2,089,970 3,939,588
Property and equipment, net 747,858 764,401
Operating lease right-of-use asset, net 981,092 1,053,641
Finance lease right-of-use asset, net 94,716 108,682
Tax receivable 105,205 105,205
Total assets 4,018,841 5,971,517
LIABILITIES AND EQUITY    
Accounts payable 1,234,080 1,235,337
Due to affiliates 13,406 5,330
Operating lease liabilities – Current 289,804 281,979
Finance lease liabilities – Current 45,095 44,255
Total current Liabilities 1,582,385 1,566,901
Deferred grant reimbursement 78,373 90,365
Operating lease liabilities - Long term 777,150 852,575
Finance lease liabilities - Long term 52,833 64,427
Total liabilities 2,490,741 2,574,268
Stockholders’ Equity:    
Preferred stock, $0.000001 par value, 5,000,000 shares authorized; no shares issued and outstanding on March 31, 2026, and December 31, 2025, respectively.
Common shares, 100,000,000 authorized shares at $0.000001; 8,478,992 and 8,406,681 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively 8 8
Additional Paid-in-capital 25,003,031 24,501,933
Accumulated deficit (23,474,939) (21,104,692)
Total equity 1,528,100 3,397,249
Total liabilities and equity $ 4,018,841 $ 5,971,517